insights_auto
Why is 0ME down 6.91%?
Dive Deeperchevron_right
0ME:FRA
Twist Bioscience Corp
€118.50
arrow_downward
-6.91%(-8.80) 1D
Oct 19, 3:25:02 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0ME...
Open
€117.15
High
€118.50
Low
€117.15
Mkt. cap
9.19B
Avg. vol.
40.00
Volume
0.00
52-wk high
€183.50
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
Open
€117.15
High
€118.50
Low
€117.15
Mkt. cap
9.19B
Avg. vol.
40.00
Volume
0.00
52-wk high
€183.50
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
News stories
From web sources and news partners
Investing.com Nigeria
·
11 hours ago
Form 144 Twist Bioscience Corp For: 18 October By Investing.com
ad-hoc-news.de
·
1 day ago
TD Cowen raises target to USD 190 for Twist Bioscience stock
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp